Hundreds of clinics may be using false and misleading statements in online advertising campaigns by offering off-label and unapproved ketamine to treat a variety of mental health and pain conditions, according to researchers at the University of Colorado Anschutz Medical Campusand Johns Hopkins University.
Related Articles
MGMA and Jackson Physician Search Extend Partnership to Enhance Physician Recruitment and Retention for Medical Practices
ENGLEWOOD, Colo. and ATLANTA , March 27, 2024 /PRNewswire/ — The Medical Group Management Association (MGMA) today announced an extended executive partnership with Jackson Physician Search, a national leader in the permanent recruitment of physicians, […]
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
WESTMINSTER, Colo.–(BUSINESS WIRE)–TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that […]
Free AI Tools Can Help Doctors Read Medical Scans—Safely and Affordably
A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more expensive commercial systems without putting […]
